MAD2L1 and breast cancer: Notably, in dataset GSE202923,[19] breast cancer cells HS578T cultured in low‐glucose conditions exhibited a significant downregulation of MAD2L1 (Figure1A), suggesting that glucose metabolism may influence the MAD2L1 signaling pathway in tumor cells.